The Effect of Bevacizumab-Related Hypertension on the Prognosis of Patients with Colorectal Cancer and Non-Small Cell Lung Cancer

被引：0
|
作者：
Pan, Juhua [1 ]
Zheng, Liangda [2 ]
Liu, Binghui [1 ]
You, Shuqing [1 ]
Zheng, Weizhi [1 ]
机构：
[1] Taizhou First Peoples Hosp, Dept Pathol, Taizhou 318020, Zhejiang, Peoples R China
[2] Taizhou First Peoples Hosp, Dept Hematol, Taizhou 318020, Zhejiang, Peoples R China
来源：
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2022年 / 84卷
关键词：
Bevacizumab; hypertension; colorectal cancer; non-small cell lung cancer; prognosis;
D O I：
10.36468/pharmaceutical-sciences.spl.448
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
To study and analyze the effect of bevacizumab-related hypertension on the prognosis of patients with colorectal cancer and non-small cell lung cancer. The study randomly selected 100 colorectal cancer patients and 100 non-small cell lung cancer patients who received therapy in our hospital from October 2019 to October 2021. Among them, adopted intervention for 100 colorectal cancer patients with bevacizumab combined with cytotoxic drug chemotherapy and adopted intervention for 100 non-small cell lung cancer patients with bevacizumab combined with standard chemotherapy. Bevacizumab treatment has better therapeutic effect of hypertension on colorectal cancer patients than non-small cell lung cancer patients. Compared with colorectal cancer patients who received bevacizumab treatment, non-small cell lung cancer patients under bevacizumab treatment caused more adverse reactions. Among 100 colorectal cancer patients, the number of patients with bevacizumab-related hypertension in grade 1, grade 2 and grade 3 were 45, 12 and 23 respectively. Among 100 non-small cell lung cancer patients, the number of patients with bevacizumab-related hypertension in grade 1, grade 2 and grade 3 were 44, 25 and 20 respectively. Bevacizumab-related hypertension can improve the prognosis and efficacy of colorectal cancer and non-small cell lung cancer patients.
引用
收藏
页码：21 / 24
页数：4
相关论文
共 50 条
  • [31] Bevacizumab: Analysis of clinical benefit in females across trials in colorectal cancer and non-small cell lung cancer
    Ramies, D. A.
    Sandler, A.
    Gray, R.
    Giantonio, B.
    Brahmer, J.
    Lyons, B.
    Schiller, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Effect of preoperative delay on prognosis for patients with early stage non-small cell lung cancer
    Quarterman, RL
    McMillan, A
    Ratcliffe, MB
    Block, MI
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (01): : 108 - 114
  • [33] Multiparametric analysis of prognosis in patients with advanced non-small cell lung cancer
    Stefan, Holdenrieder
    von, Pawel J.
    Raith, H.
    Feldmann, K.
    Stenman, U. H.
    Nagel, D.
    Stieber, P.
    TUMOR BIOLOGY, 2006, 27 : 40 - 40
  • [34] Prognosis of pulmonary lymphangitic carcinomatosis in patients with non-small cell lung cancer
    Im, Yunjoo
    Lee, Hyewon
    Lee, Ho Yun
    Baek, Sun-Young
    Jeong, Byeong-Ho
    Lee, Kyungjong
    Kim, Hojoong
    Kwon, O. Jung
    Han, Joungho
    Lee, Kyung Soo
    Ahn, Myung-Ju
    Kim, Jhingook
    Um, Sang-Won
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4130 - +
  • [35] Prognosis of non-small cell lung carcinoma in patients with previous gastric cancer
    Tsubokawa, Norifumi
    Mimae, Takahiro
    Aokage, Keiju
    Hattori, Aritoshi
    Suzuki, Kenji
    Nagal, Kenji
    Tsubol, Masahiro
    Okada, Morihito
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Prognosis in HIV-infected patients with non-small cell lung cancer
    K Sigel
    K Crothers
    R Dubrow
    K Krauskopf
    J Jao
    C Sigel
    A Moskowitz
    J Wisnivesky
    British Journal of Cancer, 2013, 109 : 1974 - 1980
  • [37] Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer
    Holdenrieder, Stefan
    Nagel, Dorothea
    Stieber, Petra
    CANCER BIOMARKERS, 2010, 6 (3-4) : 179 - 190
  • [38] Prognosis in HIV-infected patients with non-small cell lung cancer
    Sigel, K.
    Crothers, K.
    Dubrow, R.
    Krauskopf, K.
    Jao, J.
    Sigel, C.
    Moskowitz, A.
    Wisnivesky, J.
    BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1974 - 1980
  • [39] Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases
    Nagai, Kanji
    Sohara, Yasunori
    Tsuchiya, Ryosuke
    Goya, Tomoyuki
    Miyaoka, Etsuo
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (04) : 282 - 286
  • [40] Osimertinib related cardiotoxicity in patients with non-small cell lung cancer
    Mensah, Samuel Akaakole
    Alruwaili, Waleed
    Ahmad, Syed
    Patel, Brijesh
    Almubarak, Mohammed
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345